In situ lymphoma imaging in a spontaneous mouse model using the Cerenkov Luminescence of F-18 and Ga-67 isotopes.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 12 2021
14 12 2021
Historique:
received:
01
03
2021
accepted:
12
10
2021
entrez:
15
12
2021
pubmed:
16
12
2021
medline:
28
1
2022
Statut:
epublish
Résumé
Cerenkov luminescence imaging (CLI) is a promising approach to image-guided surgery and pathological sampling. It could offer additional advantages when combined to whole-body isotope tomographies. We aimed to obtain evidence of its applicability in lymphoma patho-diagnostics, thus we decided to investigate the radiodiagnostic potential of combined PET or SPECT/CLI in an experimental, novel spontaneous high-grade B-cell lymphoma mouse model (Bc.DLFL1). We monitored the lymphoma dissemination at early stage, and at clinically relevant stages such as advanced stage and terminal stage with in vivo 2-deoxy-2-[
Identifiants
pubmed: 34907289
doi: 10.1038/s41598-021-03505-3
pii: 10.1038/s41598-021-03505-3
pmc: PMC8671545
doi:
Substances chimiques
Gallium Radioisotopes
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Gallium-67
4LJK511Z86
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24002Informations de copyright
© 2021. The Author(s).
Références
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):133-40
pubmed: 23064544
J Nucl Med. 2017 Jan;58(1):175-180
pubmed: 27539844
Semin Nucl Med. 2018 Jul;48(4):359-366
pubmed: 29852945
Eur J Haematol. 1993 Oct;51(4):206-8
pubmed: 8243608
EJNMMI Radiopharm Chem. 2019 Oct 11;4(1):27
pubmed: 31659527
Cancer. 2019 Sep 15;125(18):3111-3120
pubmed: 31287161
Blood Rev. 2016 Nov;30(6):477-491
pubmed: 27596109
J Biophotonics. 2018 Oct;11(10):e201800093
pubmed: 29770603
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200
pubmed: 19915839
PET Clin. 2019 Jul;14(3):317-329
pubmed: 31084772
Nanomedicine. 2019 Apr;17:62-70
pubmed: 30654183
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2136-44
pubmed: 21858528
J Immunol. 2020 Jan 1;204(1):23-36
pubmed: 31767783
Semin Nucl Med. 2018 Jan;48(1):76-81
pubmed: 29195620
Philos Trans A Math Phys Eng Sci. 2011 Nov 28;369(1955):4605-19
pubmed: 22006909
Nature. 2000 Feb 3;403(6769):503-11
pubmed: 10676951
J Nucl Med. 2017 Jun;58(6):891-898
pubmed: 27932562
Cancer Metastasis Rev. 2012 Jun;31(1-2):89-97
pubmed: 22134656
N Engl J Med. 2018 Apr 12;378(15):1396-1407
pubmed: 29641966
Semin Nucl Med. 2018 Jan;48(1):4-16
pubmed: 29195617
Clin Transl Imaging. 2016;4(5):353-366
pubmed: 27738626
Haematologica. 2016 Oct;101(10):1244-1250
pubmed: 27354024
Mol Imaging. 2011 Jun;10(3):177-86, 1-3
pubmed: 21496448
Eur J Nucl Med Mol Imaging. 2003 Jun;30 Suppl 1:S65-81
pubmed: 12644887
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Int J Hematol. 2018 Feb;107(2):194-200
pubmed: 28994017
Phys Med. 2015 Mar;31(2):120-9
pubmed: 25555905
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2624-2632
pubmed: 32242253
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771
Theranostics. 2018 Jul 01;8(14):3991-4002
pubmed: 30083276
Br J Cancer. 1995 Dec;72(6):1541-6
pubmed: 8519674
Br J Haematol. 2016 Jul;174(1):43-56
pubmed: 27196701
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Nucl Med Biol. 2014 Jul;41(6):441-9
pubmed: 24776093
J Nucl Med. 2000 Dec;41(12):2089-97
pubmed: 11138697
Pathol Oncol Res. 2016 Apr;22(2):421-30
pubmed: 26584567
Blood. 2011 May 12;117(19):5019-32
pubmed: 21300984
Nucl Med Biol. 2017 Mar;46:12-18
pubmed: 27915165
Nucl Med Biol. 2020 Jan - Feb;80-81:57-64
pubmed: 31889612
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):517-532
pubmed: 27844106
PLoS One. 2012;7(2):e31402
pubmed: 22363636
Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1283-91
pubmed: 23674205
Semin Nucl Med. 2018 Jan;48(1):50-66
pubmed: 29195618
J Clin Oncol. 2007 Feb 10;25(5):571-8
pubmed: 17242397
PET Clin. 2016 Jan;11(1):57-64
pubmed: 26590444
Ann Oncol. 2011 Feb;22(2):405-10
pubmed: 20675560
J Biomed Opt. 2016 May 1;21(5):50502
pubmed: 27156713
Crit Rev Oncol Hematol. 2013 Aug;87(2):146-71
pubmed: 23375551
Pathology. 2018 Jan;50(1):74-87
pubmed: 29167021